Rosmarinic acid reverses non‐small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rosmarinic acid reverses non‐small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-01-27
DOI
10.1002/ptr.6584
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
- (2019) Alberto Cruz-Bermúdez et al. FREE RADICAL BIOLOGY AND MEDICINE
- Rosmarinic acid and siRNA combined therapy represses Hsp27 (HSPB1) expression and induces apoptosis in human glioma cells
- (2018) Aslıhan Şengelen et al. CELL STRESS & CHAPERONES
- Arsenic trioxide preferentially binds to the ring finger protein PML: understanding target selection of the drug
- (2018) Cao Kaiming et al. Metallomics
- Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p
- (2018) Chen Yu et al. BIOMEDICINE & PHARMACOTHERAPY
- Rosmarinic Acid Combined with Adriamycin Induces Apoptosis by Triggering Mitochondria-Mediated Signaling Pathway in HepG2 and Bel-7402 Cells
- (2018) Youxia Huang et al. MEDICAL SCIENCE MONITOR
- Current scenario of artemisinin and its analogues for antimalarial activity
- (2018) Akriti Kumari et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database
- (2017) Xia Wang et al. NUCLEIC ACIDS RESEARCH
- Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
- (2016) Zhaolin Chen et al. CANCER LETTERS
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
- (2016) D.A. Fennell et al. CANCER TREATMENT REVIEWS
- Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways
- (2016) Lei Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance
- (2015) Shuaizhang Li et al. Anti-Cancer Agents in Medicinal Chemistry
- Production and applications of rosmarinic acid and structurally related compounds
- (2015) Gun-Dong Kim et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter
- (2015) John C. Ashton CANCER RESEARCH
- The Cellular Protective Effects of Rosmarinic Acid: From Bench to Bedside
- (2015) Seyed Nabavi et al. CURRENT NEUROVASCULAR RESEARCH
- The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
- (2015) Michael M. Gottesman et al. JNCI-Journal of the National Cancer Institute
- The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
- (2015) Michael M. Gottesman et al. JNCI-Journal of the National Cancer Institute
- P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
- (2015) Hossam M. Abdallah et al. Journal of Advanced Research
- Anti-inflammatory Effect of Rosmarinic Acid and an Extract ofRosmarinus officinalisin Rat Models of Local and Systemic Inflammation
- (2014) Joao Rocha et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
- (2014) Young Choi et al. CURRENT PHARMACEUTICAL DESIGN
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Rosmarinic Acid Extract for Antioxidant, Antiallergic, and α-Glucosidase Inhibitory Activities, Isolated by Supramolecular Technique and Solvent Extraction from Perilla Leaves
- (2014) Fengxian Zhu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Pluronics and MDR Reversal: An Update
- (2014) Daria Y. Alakhova et al. MOLECULAR PHARMACEUTICS
- Effect of lyophilized grapefruit juice on P-glycoprotein-mediated drug transportin-vitroandin-vivo
- (2013) Iman S. Ahmed et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Reversal effect of rosmarinic acid on multidrug resistance in SGC7901/Adr cell
- (2013) Fa-Rong Li et al. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
- Accurate Models for P-gp Drug Recognition Induced from a Cancer Cell Line Cytotoxicity Screen
- (2013) Jurica Levatić et al. JOURNAL OF MEDICINAL CHEMISTRY
- Collateral sensitivity as a strategy against cancer multidrug resistance
- (2012) Kristen M. Pluchino et al. DRUG RESISTANCE UPDATES
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-κB
- (2009) H. Bark et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy—A Quick Review
- (2009) Fu-Shing Liu Taiwanese Journal of Obstetrics & Gynecology
- Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
- (2008) Shu-Feng Zhou et al. CURRENT MEDICINAL CHEMISTRY
- Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials
- (2007) Anand Rajeswaran et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started